Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment
Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announced topline results from ARCHER, the company's Phase II clinical study involving patients with acute myocarditis.
In...
Vertex’s stock climbs as non-opioid pain treatment advances
Vertex Pharmaceuticals shares gained ground early Thursday after the company signaled progress in the development of its experimental non-opioid pain treatment.
Source link
FDA grants nipocalimab second breakthrough therapy designation By Investing.com
SPRING HOUSE, Pa. - Johnson & Johnson (NYSE: JNJ) disclosed today that the U.S. Food and Drug Administration (FDA) has awarded Breakthrough Therapy designation...
Recent advancements in treatment of age-related macular degeneration
Recent advancements in treatment of age-related macular degeneration ...
Alzheimer’s breakthrough as scientists discover ’cause and treatment’ – Health –...
Scientists have discovered that a simple old remedy could be both the cause and potential treatment for Alzeheimer's in a major breakthrough.After nearly...
Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the...
Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry
MADISON, Wis.,...
Breakthrough discovery points to potential treatment for rare neurodegenerative disease
Imagine being middle-aged and starting to feel that you are off balance...
HIV/Aids breakthrough not a ‘cure’, popular social media posts misrepresent the...
Deliberately misleading headline and image shared alongside text copied from genuine news storyThese posts include paragraphs of text, describing the scientific breakthrough. They begin: A...
Exploring the Impact of Itch and Treatment Advances in Prurigo Nodularis
Video content above is prompted by the following: Prurigo nodularis represents one of the most severe itch conditions in dermatology, with patients typically reporting...